Tenaya Therapeutics, Inc. (TNYA) Discusses Initial Data From RIDGE-1 Phase Ib/II Trial of TN-401 Gene Therapy for ARVC Prepared Remarks Transcript
Michelle CorralVice President of Investor Relationship & Corporate Communications Hi, everyone, and thank you for joining us today. I'm Michelle...
